AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$413M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$335M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$311M |
| 5 |
Microsoft
MSFT
|
+$303M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$260M |
| 2 |
Medtronic
MDT
|
+$239M |
| 3 |
T-Mobile US
TMUS
|
+$221M |
| 4 |
CELG
Celgene Corp
CELG
|
+$204M |
| 5 |
Nike
NKE
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Financials | 15.59% |
| 3 | Healthcare | 14.73% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Universal Electronics
UEIC
$57.8M
| $596K | ﹤0.01% |
14,520
+5,400
| +59% | +$216K |
|
|
TEN
2527
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $596K | ﹤0.01% |
53,720
-23,200
| -30% | -$379K |
|
2528
Akebia Therapeutics
AKBA
$354M
| $594K | ﹤0.01% |
122,819
+9,000
| +8% | +$51.2K |
|
|
LCI
2529
DELISTED
Lannett Company, Inc.
LCI
| $593K | ﹤0.01% |
24,475
+7,275
| +42% | +$192K |
|
2530
Impinj
PI
$4.62B
| $592K | ﹤0.01% |
20,700
-2,100
| -9% | -$51.2K |
|
|
EIDX
2531
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $591K | ﹤0.01% |
19,000
+6,700
| +54% | +$182K |
|
|
DCPH
2532
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $589K | ﹤0.01% |
26,100
-496,781
| -95% | -$11.6M |
|
2533
ADT
ADT
$5.58B
| $586K | ﹤0.01% |
95,683
+29,950
| +46% | +$191K |
|
2534
1-800-Flowers.com
FLWS
$250M
| $585K | ﹤0.01% |
31,000
+1,100
| +4% | +$21K |
|
2535
Dime Commercial Bancshares
DCOM
$1.8B
| $583K | ﹤0.01% |
19,781
+300
| +2% | +$8.91K |
|
2536
Viking Therapeutics
VKTX
$3.7B
| $583K | ﹤0.01% |
70,300
| – | – |
|
2537
Forrester Research
FORR
$223M
| $578K | ﹤0.01% |
12,300
+4,200
| +52% | +$202K |
|
|
WAIR
2538
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $578K | ﹤0.01% |
52,100
+8,300
| +19% | +$79.6K |
|
|
ORC
2539
Orchid Island Capital
ORC
$1.3B
| $575K | ﹤0.01% |
18,080
+2,575
| +17% | +$83.6K |
|
2540
Quanterix
QTRX
$164M
| $574K | ﹤0.01% |
17,000
+5,200
| +44% | +$135K |
|
|
ACHN
2541
DELISTED
Achillion Pharmaceuticals
ACHN
| $574K | ﹤0.01% |
214,100
+17,200
| +9% | +$50.8K |
|
|
CPRX
2542
DELISTED
Catalyst Pharmaceutical
CPRX
| $571K | ﹤0.01% |
148,800
+59,700
| +67% | +$258K |
|
|
HTBK
2543
DELISTED
Heritage Commerce
HTBK
| $570K | ﹤0.01% |
46,529
-200,982
| -81% | -$2.47M |
|
2544
Wave Life Sciences
WVE
$1.09B
| $569K | ﹤0.01% |
21,800
| – | – |
|
|
BGG
2545
DELISTED
Briggs & Stratton Corp.
BGG
| $566K | ﹤0.01% |
55,265
+10,114
| +22% | +$114K |
|
|
HUD
2546
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $565K | ﹤0.01% |
41,000
-2,200
| -5% | -$32.2K |
|
2547
Vishay Precision Group
VPG
$1.22B
| $553K | ﹤0.01% |
13,600
+600
| +5% | +$22.7K |
|
2548
Domo
DOMO
$174M
| $552K | ﹤0.01% |
20,200
-188,200
| -90% | -$6.54M |
|
2549
Peoples Bancorp
PEBO
$1.5B
| $552K | ﹤0.01% |
17,120
+270
| +2% | +$8.62K |
|
2550
Ethan Allen Interiors
ETD
$570M
| $551K | ﹤0.01% |
26,154
+12,800
| +96% | +$269K |
|
Similar funds
AllianceBernstein's Q2 2019 Portfolio in Review
As of Q2 2019, AllianceBernstein held 3,270 positions worth $161B, up 4.8% from $154B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AllianceBernstein's Q2 2019 filing shows 163 new, 1,818 increased, 1,043 reduced and 130 closed positions. Its largest new stake was Smartsheet Inc.: 1,910,302 shares worth $92.5M. The largest sale was Apple, an estimated $260M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q2 2019 buy was Smartsheet Inc.: 1,910,302 shares worth $92.5M.
- AllianceBernstein added most to UnitedHealth in Q2 2019, an estimated $413M increase.
- AllianceBernstein's biggest Q2 2019 reduction was Apple, cutting an estimated $260M.
- AllianceBernstein fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2019, selling an estimated $177M.
- AllianceBernstein's ten largest holdings make up 18% of its $161B portfolio in Q2 2019.
- AllianceBernstein opened 163 new positions and closed 130 in Q2 2019.
- AllianceBernstein's portfolio value rose 4.8% quarter-over-quarter to $161B.
Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.